Literature DB >> 29787347

STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies.

Brad Bolon1, Georg Krinke2, Mark T Butt3, Deepa B Rao4, Ingrid D Pardo5, Bernard S Jortner6, Robert H Garman7, Karl Jensen8, Lydia Andrews-Jones9, James P Morrison10, Alok K Sharma11, Michael S Thibodeau12.   

Abstract

Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology "best practice" recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four different situations encountered during nonclinical general toxicity (screening) and dedicated neurotoxicity studies. For toxicity studies where neurotoxicity is unknown or not anticipated (situation 1), PNS evaluation may be limited to one sensorimotor spinal nerve. If somatic PNS neurotoxicity is suspected (situation 2), analysis minimally should include three spinal nerves, multiple dorsal root ganglia, and a trigeminal ganglion. If autonomic PNS neuropathy is suspected (situation 3), parasympathetic and sympathetic ganglia should be assessed. For dedicated neurotoxicity studies where a neurotoxic effect is expected (situation 4), PNS sampling follows the strategy for situations 2 and/or 3, as dictated by functional or other compound/target-specific data. For all situations, bilateral sampling with unilateral processing is acceptable. For situations 1-3, PNS is processed conventionally (immersion in buffered formalin, paraffin embedding, and hematoxylin and eosin staining). For situation 4 (and situations 2 and 3 if resources and timing permit), perfusion fixation with methanol-free fixative is recommended. Where PNS neurotoxicity is suspected or likely, at least one (situations 2 and 3) or two (situation 4) nerve cross sections should be postfixed with glutaraldehyde and osmium before hard plastic resin embedding; soft plastic embedding is not a suitable substitute for hard plastic. Special methods may be used if warranted to further characterize PNS findings. Initial PNS analysis should be informed, not masked ("blinded"). Institutions may adapt these recommendations to fit their specific programmatic requirements but may need to explain in project documentation the rationale for their chosen PNS sampling, processing, and evaluation strategy.

Entities:  

Keywords:  best practices; ganglia; nerve; neuropathology; neurotoxicity; peripheral nervous system; tissue processing; tissue sampling

Mesh:

Year:  2018        PMID: 29787347     DOI: 10.1177/0192623318772484

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  4 in total

Review 1.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

2.  Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species.

Authors:  Kelly A Fader; Ingrid D Pardo; Ramesh C Kovi; Christopher J Somps; Helen Hong Wang; Vishal S Vaidya; Shashi K Ramaiah; Madhu P Sirivelu
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-28       Impact factor: 5.849

3.  Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease.

Authors:  Brian T Welsh; Shaun M Cote; Deborah Meshulam; Justin Jackson; Ajai Pal; Janice Lansita; Ashish Kalra
Journal:  Int J Toxicol       Date:  2021 Jul-Aug       Impact factor: 2.380

4.  Orally administered branaplam does not impact neurogenesis in juvenile mice, rats, and dogs.

Authors:  Diethilde Theil; Reginald Valdez; Katy Darribat; Arno Doelemeyer; Rajeev Sivasankaran; Andreas Hartmann
Journal:  Biol Open       Date:  2021-10-28       Impact factor: 2.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.